Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
667,728
-
Shares change
-
-116,545
-
Total reported value, excl. options
-
$4,338,000
-
Value change
-
-$908,924
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$6.5
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2017
16 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2017.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 667,728 shares
.
Largest 10 shareholders include HEARTLAND ADVISORS INC (225,000 shares), PERRITT CAPITAL MANAGEMENT INC (133,800 shares), RENAISSANCE TECHNOLOGIES LLC (98,200 shares), SHUFRO ROSE & CO LLC (49,791 shares), VANGUARD GROUP INC (32,566 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (26,711 shares), WELLS FARGO & COMPANY/MN (24,702 shares), Essex Financial Services, Inc. (23,776 shares), MORGAN STANLEY (19,440 shares), and Minerva Advisors LLC (14,559 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.